Jessie Ni
VP of Product Development BioLegend
Seminars
Wednesday 16th September 2026
USP1043 Compliant GMP-Grade Cell Culture Reagent Supporting Cell-Based Immunotherapy From Bench to Bioprocess
2:30 pm
- Introducing scientists to strategies for scalable pluripotent and/or mesenchymal stem cell culture, with a focus on how GMP-grade reagents that align with USP<1043> can streamline translation into bioprocessing and clinical manufacturing
- Examining key considerations, in addition to potency and performance, in selecting and qualifying ancillary materials to minimize redevelopment timelines and accelerate regulatory readiness
- Understanding how coupling GMP-ready platforms with compliant reagents drives robust innovation and assures a smooth path to recognize its clinical and therefore commercial values
